Porwal, an alumnus of IIT-B and ISB, brings two decades of founder and senior leadership experience in the Indian startup ecosystem
2070 Health announced the strategic appointment of Gaurav Porwal as Chief Operating Officer and Operating Partner. Porwal will lead portfolio management and work closely with the founders and operating teams of 2070 Health to drive the growth and success of 2070 Health’s portfolio companies.
Porwal, an alumnus of IIT-B and ISB, brings two decades of founder and senior leadership experience in the Indian startup ecosystem and has a proven track record of building and scaling businesses, including his successful exit from Sparsh NephroCare, which was acquired by Fresenius Medical Care in 2016. His experience spans multiple consumer and healthcare ventures, including Ola Cabs (COO - Global Mobility) and Tata Digital (SVP – Service Commerce) where he built businesses across healthcare, food delivery and mobility for Tata Group's super-app, Tata Neu.
Porwal said, "I'm delighted to be part of a team that shares my passion for revolutionising healthcare. I look forward to collaborating with our founders and team members to drive meaningful change and impact. I hope that my experience and expertise in incubating & scaling companies across diverse domains will help the 2070 Heath team to solve some of healthcare’s most pressing challenges."
"We are thrilled to welcome Gaurav to our team", said Dr Pankaj Jethwani, CEO, 2070 Health. "His deep understanding of the healthcare ecosystem and entrepreneurial spirit will be invaluable in helping our founders navigate the complexities of building and scaling successful startups."
2070 Health plans to launch 8-10 start-ups over the next three to four years and will also expand operations outside India over the coming years. With Porwal's appointment, 2070 Health reinforces its commitment to building a robust ecosystem of healthcare startups. As the studio expands its operations and launches new startups, Porwal's strategic guidance will be instrumental in shaping the future of healthcare and realising the studio's bold vision.
